Literature DB >> 9917276

Guaianolides as immunomodulators. Synthesis and biological activities of dehydrocostus lactone, mokko lactone, eremanthin, and their derivatives.

S Yuuya1, H Hagiwara, T Suzuki, M Ando, A Yamada, K Suda, T Kataoka, K Nagai.   

Abstract

The naturally occurring guaianolides, namely mokko lactone (1), dehydrocostus lactone (2), eremanthin (3), and related guaianolides, 16, 17, 21, 22, 28-31, 33, 36, 37, and 39, have been synthesized starting from l-alpha-santonin in an effort to examine their structure-activity relationship as inhibitors of the killing function of cytotoxic T lymphocytes (CTL) and the induction of intercellular adhesion molecule-1 (ICAM-1). It was observed during the present study that the guaianolides possessing an alpha-methylene gamma-lactone moiety, i.e., 2, 3, 30, 33, 37, and 39, exhibited significant inhibitory activity toward the killing function of CTL and the induction of ICAM-1.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 9917276     DOI: 10.1021/np980092u

Source DB:  PubMed          Journal:  J Nat Prod        ISSN: 0163-3864            Impact factor:   4.050


  11 in total

1.  An allenic Pauson-Khand approach to 6,12-guaianolides.

Authors:  Francois Grillet; Chaofeng Huang; Kay M Brummond
Journal:  Org Lett       Date:  2011-11-09       Impact factor: 6.005

2.  Allylative Approaches to the Synthesis of Complex Guaianolide Sesquiterpenes from Apiaceae and Asteraceae.

Authors:  Xirui Hu; Andrew J Musacchio; Xingyu Shen; Yujia Tao; Thomas J Maimone
Journal:  J Am Chem Soc       Date:  2019-09-06       Impact factor: 15.419

Review 3.  Natural products possessing protein tyrosine phosphatase 1B (PTP1B) inhibitory activity found in the last decades.

Authors:  Cheng-Shi Jiang; Lin-fu Liang; Yue-wei Guo
Journal:  Acta Pharmacol Sin       Date:  2012-09-03       Impact factor: 6.150

4.  Dehydrocostuslactone suppresses angiogenesis in vitro and in vivo through inhibition of Akt/GSK-3β and mTOR signaling pathways.

Authors:  Chih-Ya Wang; An-Chi Tsai; Chieh-Yu Peng; Ya-Ling Chang; Kuo-Hsiung Lee; Che-Ming Teng; Shiow-Lin Pan
Journal:  PLoS One       Date:  2012-02-16       Impact factor: 3.240

5.  Vlasouliolides A-D, four rare C17/C15 sesquiterpene lactone dimers with potential anti-inflammatory activity from Vladimiria souliei.

Authors:  Li-Ping Chen; Guo-Zhen Wu; Jian-Ping Zhang; Ji Ye; Qing-Xin Liu; Yun-Heng Shen; Hui-Liang Li; Wei-Dong Zhang
Journal:  Sci Rep       Date:  2017-03-03       Impact factor: 4.379

6.  Dehydrocostus lactone inhibits cell proliferation and induces apoptosis by PI3K/Akt/Bad and ERS signalling pathway in human laryngeal carcinoma.

Authors:  Ren Zhang; Ji Hao; Qingming Wu; Kaiwen Guo; Chao Wang; Wei Kevin Zhang; Wanxin Liu; Qiang Wang; Xinzhou Yang
Journal:  J Cell Mol Med       Date:  2020-04-21       Impact factor: 5.310

7.  Inhibition of thioredoxin-interacting protein may enhance the therapeutic effect of dehydrocostus lactone in cardiomyocytes under doxorubicin stimulation via the inhibition of the inflammatory response.

Authors:  Xuezhi Zhang; Cuiyu Chu; Yuankun Huang
Journal:  Exp Ther Med       Date:  2022-01-18       Impact factor: 2.447

8.  Antimicrobial Effects and Active Compounds of the Root of Aucklandia Lappa Decne (Radix Aucklandiae).

Authors:  Xuewei Cai; Chunping Yang; Guangwei Qin; Min Zhang; Yan Bi; Xiaoyan Qiu; Liya Lu; Huabao Chen
Journal:  Front Chem       Date:  2022-04-06       Impact factor: 5.545

9.  The constituents of Michelia compressa var. formosana and their bioactivities.

Authors:  Yu-Yi Chan; Shin-Hun Juang; Guan-Jhong Huang; Yu-Ren Liao; Yu-Fon Chen; Chia-Che Wu; Hui-Ting Chang; Tian-Shung Wu
Journal:  Int J Mol Sci       Date:  2014-06-17       Impact factor: 5.923

10.  Isolation of betulinic acid, its methyl ester and guaiane sesquiterpenoids with protein tyrosine phosphatase 1B inhibitory activity from the roots of Saussurea lappa C.B.Clarke.

Authors:  Ji Young Choi; Minkyun Na; In Hyun Hwang; Seung Ho Lee; Eun Young Bae; Bo Yeon Kim; Jong Seog Ahn
Journal:  Molecules       Date:  2009-01-08       Impact factor: 4.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.